HAPPI magazine reports that Ulthera Inc., a Mesa, AZ company has gained Food and Drug Administration approval to market a new device that can help cure saggy skin.
The device is already for sale to plastic surgeons and dermatologists for facial tightening and eyebrow lifting and the company claims to be developing a handheld version for consumers that will treat acne and rejuvenate skin. The dermatologist version sells for $89,000, so let’s hope the home version is just a tad cheaper. It will also be interesting to see how its anti-acne efficacy stacks up against other beauty gadgets like Thermaclear.
Loading ...
{ 8 comments… read them below or add one }
That is one amazing photo accompaniment, you find some real winners.
That photo is surreal. Curious about this new device – keep us in the loop BB!
Wow…can’t wait to check that one out. I just got my newest edition of Happi in the mail today, so I will definitely see if it is there. Keep us posted if you learn more. Thanks!
Finally the modern sumo wrestler can conform to western aesthetic ideals when it travels in the highly competitive global economy of beauty! The sumo can compete in Japan on Friday and then in a Mr. Universe competition on Monday. What an exciting time to be alive! This really does show how technology can help make even the strangest marketable.
I’m skeptical…first the company claimed it might also treat cancer, according to the article (“…can be used to treat everything from sagging skin to certain types of cancer).
Obviously the FDA is stricter on cancer treatments than on cosmetics. Let’s see when it comes out if it actually works.
Oie! That’s actually difficult to look at.
I would love to find something that helps with saggy skin due to stretch marks,was wondering if tretinoin would help a little bit….. For now will keep the hope on laser treatments performed by a derm.
Whereas I am not as bad off as the man in your picture, I have lost 100 pounds. The sagging skin is an issue and it gives me hope that their might an alternative to surgery.